SS Innovations Names Vicarious Surgical Vet Sarah Romano as CFO Amid Global Push
SSII is trading near its 52-week low of $3.11 (14% above the low) on light trading volume (0.3× avg).
Summary
SS Innovations appointed Sarah M. Romano as CFO, effective August 3. She brings over 20 years of medtech finance experience, having raised more than $100 million and previously served as CFO at Vicarious Surgical, where she focused on cash burn reduction and balance sheet strengthening. The hire comes as the company pursues FDA clearance for its SSi Mantra robotic system and expands internationally. Separately, the company graduated the first class of its cardiac robotic surgery training program, with 33 professionals from seven countries, reinforcing its surgeon education efforts. The CFO appointment adds public-company financial expertise at a critical juncture, with the company carrying a going concern warning and an active $50 million ATM offering. Romano's capital markets background may support future financing needs.
At the time of this announcement, SSII was trading at $3.56 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $711.5M. The 52-week trading range was $3.11 to $10.00. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: FinanceWire.